Roche Holding Aktiengesellschaft - ADR operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Roche Holding Aktiengesellschaft - ADR with three other
companies in this sector in the United States:
sales of $50.36 billion
of which 60%
Merck & Co. , Inc.
of which 88%
was Merck Pharmaceutical), and
of which 44%
was Operating Segment-Global Established Pha).
Roche Holding Aktiengesellschaft - ADR reported sales of $49.93 billion
December of 2015.
decrease of 3.4%
versus 2014, when the company's sales were $51.68 billion.
The sales level in 2015 was fairly close to the level five years ago: in 2010, Roche Holding Aktiengesellschaft - ADR had sales
of $45.86 billion.
Contributing to the drop in overall sales was the 4.3% decline
in Diagnostics, from $11.72 billion to $11.22 billion.
There were also decreases in sales in
Pharmaceuticals (down 3.1% to $38.72 billion)